State:
Not Disclosed
Category:
Asking Price:
$12,000,000
Revenue:
$5,500,000
Company Overview
PRIME exits and American Healthcare Capital are pleased to exclusively introduce an industry-leading Mental Health Services provider in the Pacific Northwest that is for sale. The company is focused on modern patient care and solutions, including Transcranial Magnetic Stimulation, Psychotherapy, Medication Management, and Spravato (esketamine) Therapy.
Financial Overview
Based on the combined sales of all managed locations in 2021 and the projected full-year consolidated results for 2024, the Company has grown revenue from $2.8 million to $5.5 million, translating into an 18.6% compound annual growth rate (“CAGR”). For the same period, Gross Profit has grown 17.6% CAGR from $1.7 million in 2021 to $3.2 million projected for 2024. Adjusted EBITDA is expected to be $1.5 million in 2024 (27%).
Asking Price
The asking price for this opportunity is $12 million.
Inquire About This Listing:
In order to learn more about our listing, you must: